SECTRA (SECT) Q3 24/25 earnings summary

Executive summary

• Achieved record customer satisfaction, winning eight Best in KLAS awards across major regions and specialties, including Digital Pathology and large hospitals in the U.S.

• Net sales for the nine-month period rose 13% year-over-year to SEK 2,326 million, with recurring revenue up 18% and cloud recurring revenue up 44%.

• Transitioning rapidly to a SaaS and cloud-based model, impacting short-term revenue and profit but expected to drive long-term growth.

• Secured a significant patent settlement in the U.S., boosting profitability by over SEK 100 million.

• High demand and strong order bookings, including a major SEK 3.1 billion cloud contract from Québec.

Financial highlights

• Operating profit rose 29% to SEK 414 million, excluding the patent settlement; including the settlement, operating profit reached SEK 524.1 million.

• Profit per share increased 60%, including the one-time patent settlement, reaching SEK 2.24.

• Cash flow from operations reached SEK 700 million, driven by advances, patent settlement, and underlying profits.

• Contracted order bookings for the nine months increased 9% to SEK 5,805.7 million, with guaranteed order bookings up 114.5%.

• Operating margin for the period was 22.5% (17.8% excluding the patent settlement), and profit margin was 23.4%.

Outlook and guidance

• Ongoing SaaS and cloud transition expected to continue impacting revenue mix and margins, with positive effects anticipated within one to two years.

• Healthcare and cybersecurity markets are expected to grow long-term, relatively unaffected by the broader economic climate.

• Emphasizes long-term growth over quarterly fluctuations, with a focus on recurring revenue and customer satisfaction.